Association between alleles, haplotypes, and amino acid variations in HLA class II genes and type 1 diabetes in Kuwaiti children

Type 1 diabetes (T1D) is a complex autoimmune disorder that is highly prevalent globally. The interactions between genetic and environmental factors may trigger T1D in susceptible individuals. HLA genes play a significant role in T1D pathogenesis, and specific haplotypes are associated with an increased risk of developing the disease. Identifying risk haplotypes can greatly improve the genetic scoring for early diagnosis of T1D in difficult to rank subgroups. This study employed next-generation sequencing to evaluate the association between HLA class II alleles, haplotypes, and amino acids and T1D, by recruiting 95 children with T1D and 150 controls in the Kuwaiti population. Significant associations were identified for alleles at the HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci, including DRB1*03:01:01, DQA1*05:01:01, and DQB1*02:01:01, which conferred high risk, and DRB1*11:04:01, DQA1*05:05:01, and DQB1*03:01:01, which were protective. The DRB1*03:01:01~DQA1*05:01:01~DQB1*02:01:01 haplotype was most strongly associated with the risk of developing T1D, while DRB1*11:04-DQA1*05:05-DQB1*03:01 was the only haplotype that rendered protection against T1D. We also identified 66 amino acid positions across the HLA-DRB1, HLA-DQA1, and HLA-DQB1 genes that were significantly associated with T1D, including novel associations. These results validate and extend our knowledge on the associations between HLA genes and T1D in Kuwaiti children. The identified risk alleles, haplotypes, and amino acid variations may influence disease development through effects on HLA structure and function and may allow early intervention via population-based screening efforts.

[1]  E. Sobngwi,et al.  The phenotype of type 1 diabetes in sub-Saharan Africa , 2023, Frontiers in Public Health.

[2]  A. Noczyńska,et al.  Prevalence of haplotype DQ2/DQ8 and celiac disease in children with type 1 diabetes , 2022, Diabetology & Metabolic Syndrome.

[3]  C. de Beaufort,et al.  Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study. , 2022, The lancet. Diabetes & endocrinology.

[4]  J. Alkaabi,et al.  HLA-DRB1 and –DQB1 Alleles, Haplotypes and Genotypes in Emirati Patients with Type 1 Diabetes Underscores the Benefits of Evaluating Understudied Populations , 2022, Frontiers in Genetics.

[5]  S. Hasson,et al.  The Association of Human Leukocyte Antigens Complex with Type 1 Diabetes in the Omani Population , 2022, Sultan Qaboos University medical journal.

[6]  M. Jacobsen,et al.  Next Generation Sequencing Identifies the HLA-DQA1*03:03 Allele in the Type 1 Diabetes Risk-Associated HLA-DQ8 Serotype , 2021, Genes.

[7]  L. Zhao,et al.  The KAG motif of HLA-DRB1 (β71, β74, β86) predicts seroconversion and development of type 1 diabetes , 2021, EBioMedicine.

[8]  L. Zhao,et al.  Nine residues in HLA-DQ molecules determine with susceptibility and resistance to type 1 diabetes among young children in Sweden , 2021, Scientific Reports.

[9]  K. Tommerdahl,et al.  Early microvascular complications in type 1 and type 2 diabetes: recent developments and updates , 2021, Pediatric Nephrology.

[10]  L. Zhao,et al.  Next-Generation HLA Sequence Analysis Uncovers Seven HLA-DQ Amino Acid Residues and Six Motifs Resistant to Childhood Type 1 Diabetes , 2020, Diabetes.

[11]  J. Ilonen,et al.  Association of HLA‐DR‐DQ alleles, haplotypes, and diplotypes with type 1 diabetes in Saudis , 2020, Diabetes/metabolism research and reviews.

[12]  M. Gomes,et al.  HLA class II genotyping of admixed Brazilian patients with type 1 diabetes according to self-reported color/race in a nationwide study , 2020, Scientific Reports.

[13]  L. Zhao,et al.  Motifs of Three HLA-DQ Amino Acid Residues (α44, β57, β135) Capture Full Association With the Risk of Type 1 Diabetes in DQ2 and DQ8 Children , 2020, Diabetes.

[14]  E. Al-Ozairi,et al.  Human Leukocyte Antigen (HLA) and Islet Autoantibodies Are Tools to Characterize Type 1 Diabetes in Arab Countries: Emphasis on Kuwait , 2019, Disease markers.

[15]  Paul Flicek,et al.  IPD-IMGT/HLA Database , 2019, Nucleic Acids Res..

[16]  E. P. Sørgjerd Type 1 Diabetes-related Autoantibodies in Different Forms of Diabetes. , 2019, Current diabetes reviews.

[17]  L. Zhao,et al.  Eleven Amino Acids of HLA-DRB1 and Fifteen Amino Acids of HLA-DRB3, 4, and 5 Include Potentially Causal Residues Responsible for the Risk of Childhood Type 1 Diabetes , 2019, Diabetes.

[18]  B. Vidan-Jeras When type 1 diabetes meets celiac disease , 2018, HLA.

[19]  A. Hajjej,et al.  Association of HLA Class II alleles and Haplotypes with Type 1 Diabetes in Tunisian Arabs. , 2018, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[20]  Å. Lernmark,et al.  Reduction in White Blood Cell, Neutrophil, and Red Blood Cell Counts Related to Sex, HLA, and Islet Autoantibodies in Swedish TEDDY Children at Increased Risk for Type 1 Diabetes , 2018, Diabetes.

[21]  G. Dhaunsi,et al.  Association of protein tyrosine phosphatase non-receptor type 22 gene functional variant C1858T, HLA-DQ/DR genotypes and autoantibodies with susceptibility to type-1 diabetes mellitus in Kuwaiti Arabs , 2018, PloS one.

[22]  M. Redondo,et al.  Genetics of type 1 diabetes , 2018, Pediatric diabetes.

[23]  V. Nicolaidou,et al.  Combined effect of glutamine at position 70 of HLA-DRB1 and alanine at position 57 of HLA-DQB1 in type 1 diabetes: An epitope analysis , 2018, PloS one.

[24]  J. Tuomilehto,et al.  Incidence of type 1 diabetes has doubled in Kuwaiti children 0‐14 years over the last 20 years , 2017, Pediatric diabetes.

[25]  R. Yamada,et al.  HLA‐HD: An accurate HLA typing algorithm for next‐generation sequencing data , 2017, Human mutation.

[26]  A. Pugliese Insulitis in the pathogenesis of type 1 diabetes , 2016, Pediatric diabetes.

[27]  Steven J Mack,et al.  Bridging ImmunoGenomic Data Analysis Workflow Gaps (BIGDAWG): An integrated case-control analysis pipeline. , 2016, Human immunology.

[28]  J. Noble Immunogenetics of type 1 diabetes: A comprehensive review. , 2015, Journal of autoimmunity.

[29]  Buhm Han,et al.  Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk , 2015, Nature Genetics.

[30]  J. Ilonen,et al.  Risk genes and autoantibodies in Egyptian children with type 1 diabetes – low frequency of autoantibodies in carriers of the HLA‐DRB1*04:05‐DQA1*03‐DQB1*02 risk haplotype , 2015, Diabetes/metabolism research and reviews.

[31]  E. Bonifacio,et al.  The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study , 2015, Diabetologia.

[32]  P. Bingley,et al.  Risk of pediatric celiac disease according to HLA haplotype and country. , 2014, The New England journal of medicine.

[33]  M. Ni,et al.  Inference of high resolution HLA types using genome-wide RNA or DNA sequencing reads , 2014, BMC Genomics.

[34]  B. Nsiri,et al.  Association of HLA-DR-DQ polymorphisms with diabetes in Tunisian patients. , 2013, Transfusion and Apheresis Science.

[35]  J. Ilonen,et al.  Patterns of β-Cell Autoantibody Appearance and Genetic Associations During the First Years of Life , 2013, Diabetes.

[36]  J. Noble,et al.  HLA Class II Genotyping of African American Type 1 Diabetic Patients Reveals Associations Unique to African Haplotypes , 2013, Diabetes.

[37]  A. Valdés,et al.  Genetics of the HLA Region in the Prediction of Type 1 Diabetes , 2011, Current diabetes reports.

[38]  M. Rewers,et al.  Genetics of type 1 diabetes. , 2011, Clinical chemistry.

[39]  W. Almawi,et al.  Influence of Common and Specific HLA-DRB1/DQB1 Haplotypes on Genetic Susceptibilities of Three Distinct Arab Populations to Type 1 Diabetes , 2008, Clinical and Vaccine Immunology.

[40]  J. Franklyn,et al.  Analysis of HLA class II genes in Hashimoto's thyroiditis reveals differences compared to Graves’ disease , 2008, Genes and Immunity.

[41]  J. Todd,et al.  HLA DR-DQ Haplotypes and Genotypes and Type 1 Diabetes Risk , 2008, Diabetes.

[42]  D. Klinke Extent of Beta Cell Destruction Is Important but Insufficient to Predict the Onset of Type 1 Diabetes Mellitus , 2008, PloS one.

[43]  M. Simmonds,et al.  The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action , 2007, Current genomics.

[44]  M. Rewers,et al.  Extreme genetic risk for type 1A diabetes , 2006, Proceedings of the National Academy of Sciences.

[45]  Pekka Laippala,et al.  Models for predicting type 1 diabetes in siblings of affected children. , 2006, Diabetes care.

[46]  Å. Lernmark,et al.  D6S265*15 marks a DRB1*15, DQB1*0602 haplotype associated with attenuated protection from type 1 diabetes mellitus , 2005, Diabetologia.

[47]  A. Motala,et al.  Contribution of selective HLA-DRB1/DQB1 alleles and haplotypes to the genetic susceptibility of type 1 diabetes among Lebanese and Bahraini Arabs. , 2005, The Journal of clinical endocrinology and metabolism.

[48]  Madeeha Kamal,et al.  Specific HLA-DRB and -DQB Alleles and Haplotypes Confer Disease Susceptibility or Resistance in Bahraini Type 1 Diabetes Patients , 2004, Clinical Diagnostic Laboratory Immunology.

[49]  T. Ogihara,et al.  Asian-specific HLA haplotypes reveal heterogeneity of the contribution of HLA-DR and -DQ haplotypes to susceptibility to type 1 diabetes. , 2002, Diabetes.

[50]  J. Dorman,et al.  High Frequency of HLA-DQB1 Non-Asp57 Alleles in Kuwaiti Children with Insulin-Dependent Diabetes mellitus , 2000, Human Heredity.

[51]  J. Dorman,et al.  Prevalence of human leukocyte antigen DQA1 and DQB1 alleles in Kuwaiti Arab children with type 1 diabetes mellitus , 1999, Clinical genetics.

[52]  S. Garg,et al.  Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study , 1999, BMJ.

[53]  T. Lybrand,et al.  Polymorphic Amino Acid Variations in HLA-DQ Are Associated With Systematic Physical Property Changes and Occurrence of IDDM , 1995, Diabetes.

[54]  A. Weetman,et al.  HLA Associations with Hashimoto's thyroiditis , 1991, Clinical endocrinology.

[55]  E. Thorsby,et al.  Distribution of HLA-DRB1, -DQA1 and -DQB1 alleles and DQA1-DQB1 genotypes among Norwegian patients with insulin-dependent diabetes mellitus. , 1991, Tissue antigens.

[56]  J. Todd,et al.  Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[57]  J. Todd,et al.  HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus , 1987, Nature.

[58]  P. Bingley,et al.  High familial risk and genetic susceptibility in early onset childhood diabetes. , 2002, Diabetes.

[59]  A. Svejgaard,et al.  HLA and insulin‐dependent diabetes: An overview , 1989, Genetic epidemiology.